It is time to reassess reporting of electroconvulsive therapy data in New Zealand: A 17-year retrospective analysis of treatment data from Waikato
While COVID-19 had broad impacts across healthcare services, it has not led to an overall change in treatments. There was, however, a noticeable shift towards more psychotic disorders treated during the pandemic. This study also provides data that Māori and Pacific Islanders are accessing electroconvulsive therapy, though rates of electroconvulsive therapy usage are still lesser on a proportional population basis. Conclusions are provided to improve national data collection and reporting standards.
Authors
- Colleen Loo (ORCID: https://orcid.org/0000-0003-3267-0554)
- Moloud Abdar (ORCID: https://orcid.org/0000-0002-3059-6357)
- Matthew Jenkins (ORCID: https://orcid.org/0000-0002-1534-8814)
- Timothy Carroll
- Robert M. Lundin (ORCID: https://orcid.org/0000-0002-5992-2822)
- Michael Berk (ORCID: https://orcid.org/0000-0002-5554-6946)
- Colin Patrick
- Savani Kannangara
- Abbas Khosravi
- Kathrine Wakefield
Institutions
- Barwon Health (AU)
- Deakin University (AU)
- University of Auckland (NZ)
- Black Dog Institute (AU)
- Geelong Hospital (AU)
- Waikato Hospital (NZ)
- Waikato District Health Board (NZ)
Publication Details
- Journal
- Australian & New Zealand Journal of Psychiatry
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1177/00048674251324795
- Primary Topic
- Electroconvulsive Therapy Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00